Back
Columbia Res Enh Emerging Econ ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
37
ECON
Columbia Res Enh Emerging Econ ETF
Last Price:
21.32
Seasonality Move:
2.18%
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
136.90
Seasonality Move:
14.88%
Sell
37
Columbia Res Enh Emerging Econ ETF (ECON)
is a Sell
Is Columbia Res Enh Emerging Econ ETF a Buy, Sell or Hold?
- The current Columbia Res Enh Emerging Econ ETF [ECON] share price is $21.19. The Score for ECON is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ECON is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ECON Stock Price Chart
What is Columbia Res Enh Emerging Econ ETF's stock price today?
-
The Columbia Res Enh Emerging Econ ETF share price today is $21.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ECON is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ECON Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 39.26 | Sell |
Chaikin Money Flow: | -25363 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.31 - 22.07) | Sell |
Bollinger Bands (100): | (20.77 - 22.23) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.3 | Sell |
Relative Strength Index (14 RSI): | 64.59 | Buy |
Chaikin Money Flow: | 3149400 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.02 - 128.88) | Buy |
Bollinger Bands (100): | (119.18 - 142.3) | Sell |
ECON Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.3 | Sell |
20-day SMA: | 21.6 | Sell |
50-day SMA: | 22.05 | Sell |
200-day SMA: | 21.15 | Buy |
8-day EMA: | 21.34 | Sell |
20-day EMA: | 21.56 | Sell |
50-day EMA: | 21.71 | Sell |
200-day EMA: | 21.26 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.07 | Buy |
20-day SMA: | 117.27 | Buy |
50-day SMA: | 121.92 | Buy |
200-day SMA: | 129.99 | Buy |
8-day EMA: | 116.28 | Buy |
20-day EMA: | 117.14 | Buy |
50-day EMA: | 121.91 | Buy |
200-day EMA: | 125.98 | Buy |
Columbia Res Enh Emerging Econ ETF Earnings Growth & ECON Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.
Columbia Res Enh Emerging Econ ETF Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |